HomeAPIsZoliflodacin
Zoliflodacin structure

Zoliflodacin

Candidate
CAS: 1620458-09-4
Sample Stock:

Zoliflodacin is a groundbreaking, first-in-class oral antibiotic specifically developed to address the global threat of antimicrobial-resistant gonorrhea. It received U.S. Food and Drug Administration (FDA) approval on December 11, 2025, for the treatment of uncomplicated urogenital gonorrhea caused by Neisseria gonorrhoeae in adults and pediatric patients 12 years of age and older weighing at least 35 kg.

Related Information

Purity:98%+
Registration:GMP/DMF
View More

Biological Profile

Associated Conditions

gonorrhea

Key Intermediates

9 Items
StructureNameCAS No.Sample StockMDL No.Inquire
2,3,4-Trifluorobenzaldehyde structure
2,3,4-Trifluorobenzaldehyde161793-17-5MFCD00061230
2,6-Dimethylmorpholine, (2R,6R)- structure
2,6-Dimethylmorpholine, (2R,6R)-171753-74-5MFCD18250270
5-(1,3-Dioxolan-2-yl)-2,3,4-trifluorobenzaldehyde oxime structure
5-(1,3-Dioxolan-2-yl)-2,3,4-trifluorobenzaldehyde oxime1620459-32-6-
(S)-6,7-Difluoro-3-(4-methyl-2-oxooxazolidin-3-yl)benzo[d]isoxazole-5-carbaldehyde structure
(S)-6,7-Difluoro-3-(4-methyl-2-oxooxazolidin-3-yl)benzo[d]isoxazole-5-carbaldehyde1802089-88-8-
3-Chloro-6,7-difluorobenzo[d]isoxazole-5-carbaldehyde structure
3-Chloro-6,7-difluorobenzo[d]isoxazole-5-carbaldehyde1223451-46-4-
2,6-Dimethylmorpholine, cis- structure
2,6-Dimethylmorpholine, cis-2098200-15-6MFCD00078428
2-(2,3,4-Trifluorophenyl)-1,3-dioxolane structure
2-(2,3,4-Trifluorophenyl)-1,3-dioxolane773102-28-6-
(4S)-3-[5-(1,3-Dioxolan-2-yl)-6,7-difluoro-1,2-benzisoxazol-3-yl]-4-methyl-2-oxazolidinone structure
(4S)-3-[5-(1,3-Dioxolan-2-yl)-6,7-difluoro-1,2-benzisoxazol-3-yl]-4-methyl-2-oxazolidinone1802089-90-2-
6-[(2R,6R)-2,6-Dimethyl-4-morpholinyl]-7-fluoro-3-[(4S)-4-methyl-2-oxo-3-oxazolidinyl]-1,2-benzisoxazole-5-carboxaldehyde structure
6-[(2R,6R)-2,6-Dimethyl-4-morpholinyl]-7-fluoro-3-[(4S)-4-methyl-2-oxo-3-oxazolidinyl]-1,2-benzisoxazole-5-carboxaldehyde1802089-86-6-